MONUDIN
Dead / Cancelled — Cancelled — Section 8 (as of 02 Apr 2021)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 85693119
- Registration number
- 4591003
- Mark type
- Stylized text
- Filed
- 01 Aug 2012
- Published for opposition
- 29 Oct 2013
- Registered
- 26 Aug 2014
- Attorney of record
- Roberta S. Bren
Goods and services
- Class 001 — Chemicals: Chemical and biochemical products for use in gene delivery technology, namely, enzymes, proteins, growth factors and chemicals for in-vitro use in laboratories and for analysis in gene delivery technology; micro-organisms, cell cultures, plasmids and cultures of micro-organisms, deoxyribonucleic acid sequences, cloning vehicles and recombinant deoxyribonucleic acid variations thereof, all for in-vivo use in gene delivery technology
- Class 005 — Pharmaceuticals: Gene therapy and prophylaxis products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of motor neurone disease, blood disorders, cancer, diseases of the nervous system, inflammatory and auto-immune diseases, vascular disorders, disorders arising from improper vascularization and single gene disorders; pharmaceutical substances and preparations namely, vaccines, genetically engineered proteins enzymes and enzyme preparations for medical diagnostic use; retroviral vector and retroviral vector manufacturing preparations for use in gene delivery; pharmaceutical and biochemical preparations for the treatment of single gene disorders
- Class 010 — Medical apparatus: Instruments and apparatus for the administration of gene and antibody-based therapy and prophylaxis preparations and substances, namely, empty vials, syringes and injectors for medical purposes, all for the treatment of single gene disorders, cancer, diseases of the nervous system, inflammatory and auto-immune diseases, blood disorders, vascular disorders and disorders arising from inappropriate vascularization
- Class 042 — Scientific and technological services: Scientific and medical research and development; genetic engineering services, biotechnology services, namely, research and development of new technology for others in the field of biotechnology; licensing of intellectual property; product development consultation relating to gene therapy products; consultation services in the fields of medical and scientific research in the field of professional gene therapy
Owner
- Oxford BioMedica plc, Oxford OX4 6LT, GB
- Oxford BioMedica plc, Oxford, GB
- Oxford BioMedica plc, Oxford, GB
Prior registrations
Prosecution history
- 02 Apr 2021 — CANCELLED SEC. 8 (6-YR)
- 26 Aug 2019 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 08 Jun 2018 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 08 Jun 2018 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 08 Jun 2018 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 08 Jun 2018 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 26 Aug 2014 — REGISTERED-PRINCIPAL REGISTER
- 22 Jul 2014 — 1(B) BASIS DELETED; PROCEED TO REGISTRATION
- 23 Jun 2014 — NOTICE OF ALLOWANCE CANCELLED
- 14 Jul 2014 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 23 Jun 2014 — TEAS POST PUBLICATION AMENDMENT RECEIVED
- 24 Dec 2013 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 29 Oct 2013 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 29 Oct 2013 — PUBLISHED FOR OPPOSITION
- 09 Oct 2013 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED